Copyright Reports & Markets. All rights reserved.

Global Short Bowel Syndrome Drugs Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Short Bowel Syndrome Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China Short Bowel Syndrome Drugs Market Performance
    • 2.3 USA Short Bowel Syndrome Drugs Market Performance
    • 2.4 Europe Short Bowel Syndrome Drugs Market Performance
    • 2.5 Japan Short Bowel Syndrome Drugs Market Performance
    • 2.6 Korea Short Bowel Syndrome Drugs Market Performance
    • 2.7 India Short Bowel Syndrome Drugs Market Performance
    • 2.8 Southeast Asia Short Bowel Syndrome Drugs Market Performance
    • 2.9 South America Short Bowel Syndrome Drugs Market Performance

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.3 USA Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.4 Europe Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.5 Japan Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.6 Korea Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.7 India Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.8 Southeast Asia Short Bowel Syndrome Drugs Market Performance (Volume)
    • 3.9 South America Short Bowel Syndrome Drugs Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Emmaus Medical
      • 4.1.1 Emmaus Medical Profiles
      • 4.1.2 Emmaus Medical Product Information
      • 4.1.3 Emmaus Medical Short Bowel Syndrome Drugs Business Performance
      • 4.1.4 Emmaus Medical Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.2 Merck
      • 4.2.1 Merck Profiles
      • 4.2.2 Merck Product Information
      • 4.2.3 Merck Short Bowel Syndrome Drugs Business Performance
      • 4.2.4 Merck Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.3 Shire
      • 4.3.1 Shire Profiles
      • 4.3.2 Shire Product Information
      • 4.3.3 Shire Short Bowel Syndrome Drugs Business Performance
      • 4.3.4 Shire Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.4 Ardelyx
      • 4.4.1 Ardelyx Profiles
      • 4.4.2 Ardelyx Product Information
      • 4.4.3 Ardelyx Short Bowel Syndrome Drugs Business Performance
      • 4.4.4 Ardelyx Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.5 Naia Pharmaceuticals
      • 4.5.1 Naia Pharmaceuticals Profiles
      • 4.5.2 Naia Pharmaceuticals Product Information
      • 4.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Business Performance
      • 4.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.6 Nutrinia
      • 4.6.1 Nutrinia Profiles
      • 4.6.2 Nutrinia Product Information
      • 4.6.3 Nutrinia Short Bowel Syndrome Drugs Business Performance
      • 4.6.4 Nutrinia Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.7 OxThera
      • 4.7.1 OxThera Profiles
      • 4.7.2 OxThera Product Information
      • 4.7.3 OxThera Short Bowel Syndrome Drugs Business Performance
      • 4.7.4 OxThera Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.8 GLyPharma Therapeutic
      • 4.8.1 GLyPharma Therapeutic Profiles
      • 4.8.2 GLyPharma Therapeutic Product Information
      • 4.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Business Performance
      • 4.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.9 Sancilio Pharmaceuticals
      • 4.9.1 Sancilio Pharmaceuticals Profiles
      • 4.9.2 Sancilio Pharmaceuticals Product Information
      • 4.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Business Performance
      • 4.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.10 Zealand Pharma
      • 4.10.1 Zealand Pharma Profiles
      • 4.10.2 Zealand Pharma Product Information
      • 4.10.3 Zealand Pharma Short Bowel Syndrome Drugs Business Performance
      • 4.10.4 Zealand Pharma Short Bowel Syndrome Drugs Business Development and Market Status
    • 4.20 Zealand Pharma

    5 Market Performance for Manufacturers

    • 5.1 Global Short Bowel Syndrome Drugs Production (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global Short Bowel Syndrome Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global Short Bowel Syndrome Drugs Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global Short Bowel Syndrome Drugs Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Global Short Bowel Syndrome Drugs Market Performance (Production Point)

    • 6.1 Global Short Bowel Syndrome Drugs Production (K Units) and Market Share by Regions 2013-2018
    • 6.2 Global Short Bowel Syndrome Drugs Revenue (M USD) and Market Share by Regions 2013-2018
    • 6.3 Global Short Bowel Syndrome Drugs Price (USD/Unit) by Regions 2013-2018
    • 6.4 Global Short Bowel Syndrome Drugs Gross Margin by Regions 2013-2018

    7 Development Trend for Regions (Production Point)

    • 7.1 Global Short Bowel Syndrome Drugs Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
    • 7.2 China Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.3 USA Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.4 Europe Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.5 Japan Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.6 Korea Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.7 India Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.8 Southeast Asia Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.9 South America Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

    8 Global Short Bowel Syndrome Drugs Market Performance (Consumption Point)

    • 8.1 Global Short Bowel Syndrome Drugs Consumption and Market Share by Regions 2013-2018
    • 8.2 Global Short Bowel Syndrome Drugs Consumption Value and Market Share by Regions 2013-2018
    • 8.3 Global Short Bowel Syndrome Drugs Price (USD/Unit) by Regions 2013-2018

    9 Development Trend for Regions (Sales Point)

    • 9.1 Global Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.2 China Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.3 USA Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.4 Europe Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.5 Japan Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.6 Korea Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.7 India Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.8 Southeast Asia Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.9 South America Short Bowel Syndrome Drugs Sales and Growth, Sales Value and Growth Rate2013-2018

    10 Upstream Source, Technology and Cost

    • 10.1 Upstream Source
    • 10.2 Technology
    • 10.3 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Consumer Analysis

    • 12.1 Hospital Pharmacies Industry
    • 12.2 Retail Pharmacies Industry
    • 12.3 Online Pharmacies Industry

    13 Market Forecast 2019-2024

    • 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 13.1.1 Global Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 13.1.2 Global Short Bowel Syndrome Drugs Production (K Units) and Growth Rate 2019-2024
      • 13.1.3 China Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.4 USA Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.5 Europe Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.6 Japan Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.7 Korea Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.8 India Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.9 Southeast Asia Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.10 South America Short Bowel Syndrome Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.2 Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.1 Global Short Bowel Syndrome Drugs Consumption and Market Share by Regions 2019-2024
      • 13.2.2 Global Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.3 China Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.4 USA Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.5 Europe Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.6 Japan Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.7 Korea Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.8 India Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.9 Southeast Asia Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.10 South America Short Bowel Syndrome Drugs Sales, Sales Value and Growth Rate 2019-2024
    • 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
      • 13.3.1 Overall Market Performance
      • 13.3.2 Oral Route Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.3 Parental Route Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.4 Sales by Application 2019-2024
      • 13.4.1 Overall Market Performance
      • 13.4.2 Hospital Pharmacies Sales and and Growth Rate 2019-2024
      • 13.4.3 Retail Pharmacies Sales and and Growth Rate 2019-2024
      • 13.4.4 Online Pharmacies Sales and and Growth Rate 2019-2024
    • 13.5 Price (USD/Unit) and Gross Profit
      • 13.5.1 Global Short Bowel Syndrome Drugs Price (USD/Unit) Trend 2019-2024
      • 13.5.2 Global Short Bowel Syndrome Drugs Gross Profit Trend 2019-2024

    14 Conclusion

    Geographically, global Short Bowel Syndrome Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Emmaus Medical
    Merck
    Shire
    Ardelyx
    Naia Pharmaceuticals
    Nutrinia
    OxThera
    GLyPharma Therapeutic
    Sancilio Pharmaceuticals
    Zealand Pharma

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    Oral Route
    Parental Route
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Short Bowel Syndrome Drugs for each application, including
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Production, consumption, revenue, market share and growth rate are the key targets for Short Bowel Syndrome Drugs from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now